Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Five Biotech Stocks That Could Be M&A Targets After the Selloff
Five Biotech Stocks That Could Be M&A Targets After the Selloff
Five Biotech Stocks That Could Be M&A Targets After the Selloff
Submitted by
admin
on September 29, 2015 - 10:30pm
Source:
Barron's
News Tags:
biotech
M&A
Merrimack
OncoMed
Clovis Oncology
Pfenex
Baxter
Headline:
Five Biotech Stocks That Could Be M&A Targets After the Selloff
Do Not Allow Advertisers to Use My Personal information
